{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:57Z","timestamp":1707524157269},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,16]]},"DOI":"10.7759\/cureus.11514","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T01:45:34Z","timestamp":1605577534000},"source":"Crossref","is-referenced-by-count":0,"title":["Linezolid Induced Lactic Acidosis: The Side Effect, Clinician Should Be Aware of"],"prefix":"10.7759","author":[{"given":"Savannah","family":"Nightingale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushboo K","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayurkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s164515","article-title":"Linezolid: a review of its properties, function, and use in critical care","volume":"12","author":"Hashemian SMR","year":"2018","unstructured":"Hashemian SMR, Farhadi T, Ganjparvar M. Linezolid: a review of its properties, function, and use in critical care. Drug Des Devel Ther. 2018, 12:1759-1767. 10.2147\/dddt.s164515","journal-title":"Drug Des Devel Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/ce.s33430","article-title":"An evidence-based review of linezolid for the treatment of methicillin-resistant staphylococcus aureus (mrsa): place in therapy","volume":"7","author":"Watkins R","year":"2012","unstructured":"Watkins R, Lemonovich TL, File JT. An evidence-based review of linezolid for the treatment of methicillin-resistant staphylococcus aureus (mrsa): place in therapy. Core Evid. 2012, 7:131. 10.2147\/ce.s33430","journal-title":"Core Evid"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.12.009","article-title":"Incidence and risk factors of linezolid-induced lactic acidosis","volume":"31","author":"Im JH","year":"2015","unstructured":"Im JH, Baek JH, Kwon HY, Lee JS. Incidence and risk factors of linezolid-induced lactic acidosis. Int J Infect Dis. 2015, 31:47-52. 10.1016\/j.ijid.2014.12.009","journal-title":"Int J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2017.1335305","article-title":"Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes","volume":"16","author":"Santini A","year":"2017","unstructured":"Santini A, Ronchi D, Garbellini M, Piga D, Protti A. Linezolid-induced lactic acidosis: the thin line between bacterial and mitochondrial ribosomes. Expert Opin Drug Saf. 2017, 16:833-843. 10.1080\/14740338.2017.1335305","journal-title":"Expert Opin Drug Saf"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/inf.0b013e3182186035","article-title":"Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children","volume":"30","author":"Su E","year":"2011","unstructured":"Su E, Crowley K, Carcillo JA, Michaels MG. Linezolid and lactic acidosis: a role for lactate monitoring with long-term linezolid use in children. Pediatr Infect Dis J. 2011, 30:804-806. 10.1097\/inf.0b013e3182186035","journal-title":"Pediatr Infect Dis J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.20","article-title":"A case of lactic acidosis induced by linezolid","volume":"6","author":"Velez JCQ","year":"2010","unstructured":"Velez JCQ, Janech MG. A case of lactic acidosis induced by linezolid. Nat Rev Nephrol. 2010, 6:236-242. 10.1038\/nrneph.2010.20","journal-title":"Nat Rev Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/0897190018782787","article-title":"A case of linezolid induced toxicity","volume":"33","author":"Tobias PE","year":"2018","unstructured":"Tobias PE, Varughese CA, Hanson AP, Gurnani PK. A case of linezolid induced toxicity. J Pharm Pract. 2018, 33:222-225. 10.1177\/0897190018782787","journal-title":"J Pharm Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2008.08.009","article-title":"Toxicity of extended courses of linezolid: results of an infectious diseases society of america emerging infections network survey","volume":"62","author":"Beekmann SE","year":"2008","unstructured":"Beekmann SE, Gilbert DN, Polgreen PM. Toxicity of extended courses of linezolid: results of an infectious diseases society of america emerging infections network survey. Diagn Microbiol Infect Dis. 2008, 62:407-410. 10.1016\/j.diagmicrobio.2008.08.009","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42558-linezolid-induced-lactic-acidosis-the-side-effect-clinician-should-be-aware-of","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:53Z","timestamp":1707506993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42558-linezolid-induced-lactic-acidosis-the-side-effect-clinician-should-be-aware-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.11514","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,16]]}}}